Skip to content
Screener

PTC Therapeutics PTCT Product — Deferred Revenue

Similar metrics at other companies

Ooma logo
OOMAProduct — Deferred Revenue
$80K+1,233%
Stereotaxis logo
STXSProduct Shipped Revenue Deferred — Deferred Revenue
$781K-56.4%
A10 Networks logo
ATENProducts — Deferred Revenue
$17.45M+188%
Cinemark Holdings logo
CNKOther Deferred Revenues — Deferred Revenue
$261.1M+5.8%
St. Joe Company logo
JOEOther Products Or Services — Deferred Revenue
$14.9M-3.2%
Yum China Holdings logo
YUMCPrepaid Stored Value Products — Deferred Revenue
$148M+24.4%

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$5.78B+41.9%
Enterprise value$5.34B+54.9%
P/E7.1×—
P/S7×+4.7×

Profitability

See full
Gross margin96%—
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%—
Debt / equity372.3×—
Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.

The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:32 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001070081-26-000012

As of March 31, 2026 and December 31, 2025, the Company does not have a contract liabilities balance related to net product sales, and has not made significant changes to the judgments made in applying ASC Topic 606.

Item 1. Financial Statements (unaudited)

FAQ

What is PTC Therapeutics's product — deferred revenue?
PTC Therapeutics (PTCT) reported product — deferred revenue of $0 in Q1 2026.
What does product — deferred revenue mean?
This represents the obligation to transfer goods or services to a customer for which the company has already received consideration or for which an amount of consideration is due. It reflects deferred revenue or performance obligations that have not yet been satisfied under existing contracts. Monitoring this balance provides insight into future revenue recognition potential and customer commitment levels.

Ask your AI about PTC Therapeutics's product — deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude